Biochemical changes in substantia nigra of patients with Parkinson disease observed by modified proton magnetic resonance spectroscopy

Peng Li,Wei Wang,Yan Gu,Yang Li,Jing Chen,Yong-hua Xu,Jing-xi Huang
DOI: https://doi.org/10.3321/j.issn:1673-8225.2006.34.026
2006-01-01
Abstract:Aim: To observe the biochemical changes of substantia nigra in patients with Parkinson disease using the improved techniques of proton magnetic resonance, so as to provide theoretic evidence for application in the pathophysiological research on Parkinson disease and clinical diagnosis. Methods: Twenty-nine primary inpatients and outpatients with Parkinson diseases in the West China Hospital of Sichuan University, diagnosed as primary Parkinson disease according to the diagnosis criteria formulated by National Symposium on Extrapyramidal Disease held in 1984 were selected as Parkinson disease group. Meanwhile, 29 healthy volunteers aged > 40 years were enrolled as control group. They received proton magnetic resonance spectroscopy (MRS) detection in Department of Radiology, West China Hospital of Sichuan University. The age, gender distribution of the examinees was basically coincident, and except Parkinson disease, they had no history of other disease of central nervous system. All the participators were informed and agreed to join the test before experiment. Their concentration of the N-Acetyl aspartic acid (NAA), Choline (Cho) and creatine (Cr) in substantia nigra were detected with the multi-voxel-MRS to find out the difference of them and the values of NAA/Cho, NAA/Cr, Cho/Cr, NAA, Cho/Cr in the two giroups. And the relationship between these changes and the pathophysiological progress of Parkinson disease were analyzed. Results: All the 58 persons received the MRS scan were involved in the result analysis. No obvious difference was found in the values of NAA/ Cho, NAA/Cr and Cho/Cr between the two groups (P > 0.05). But the concentrations of the NAA and Cho of the patients with Parkinson disease were lower compared with the healthy people (P < 0.05). Conclusion: The multi-voxal proton magnetic resonance spectroscopy scan can better detect the metabolic changes of the central neural system in living persons and the results of the test can help the diagnosis and researches of the pathophysiologial progress of Parkinson disease.
What problem does this paper attempt to address?